Tracing disease emergence: canine babesiosis in the UK

Occurrence, management and outcome of immune-complex glomerulonephritis in dogs with suspected glomerulopathy in the UK

OBJECTIVES

To determine the proportion of dogs diagnosed with immune-complex glomerulonephritis in a large cohort of UK dogs with clinical suspicion of glomerular disease in which renal histopathology, including routine light microscopy, transmission electron microscopy and immunofluorescence, had been performed. The second objective was to describe treatment and long-term clinical outcome of dogs diagnosed with immune-complex glomerulonephritis.

MATERIALS AND METHODS

Sixty-two UK dogs that underwent renal biopsies for investigation of suspected glomerulopathy (urine protein-to-creatinine ratio persistently >0.5) were included in this retrospective multicentre study. Signalment, clinico-pathological abnormalities, histopathological diagnosis, treatment following diagnosis and survival were recorded.

RESULTS

Seventeen (27%) of the dogs with suspected glomerular disease were diagnosed with immune-complex glomerulonephritis and nine (53%) of these were still alive at the study end point, with a median follow-up of 366 days (range 52 to 1299). Six dogs diagnosed with immune-complex glomerulonephritis were treated with mycophenolate. Four received mycophenolate alone for immunosuppression and two received mycophenolate and chlorambucil; all these six dogs were alive at data collection [median follow-up time 712.5 days (range 73 to 1299)]. Seven dogs diagnosed with immune-complex glomerulonephritis did not receive immunosuppressive treatment; only one of these dogs was alive at study end point [median survival time 302 days (range 52 to 723)].

CLINICAL SIGNIFICANCE

Immune-complex glomerulonephritis may be less common in the UK than previously reported in North America and mainland Europe, reducing the likelihood of treatment modification following renal biopsy. Mycophenolate was the most commonly used immunosuppressant for cases of immune-complex glomerulonephritis.

Potential risk posed by the importation of ticks into the UK on animals: records from the Tick Surveillance Scheme

In order to monitor important tick vectors in the UK, Public Health England's Tick Surveillance Scheme (TSS) receives specimens from across the country for identification. In recent years, an increasing number of these specimens have been removed from animals with a recent history of travel outside the UK. This paper presents all data collated by the TSS on ticks entering the country on recently travelled or imported animals since surveillance commenced in 2005. Ten different tick species representing six different genera were identified, entering the UK from 15 different countries. Key themes appear to be emerging from the last 10 years of data, including canine travel from Cyprus and Spain being associated with Rhipicephalus sanguineus importation, and canine travel from France being associated with the importation of multiple tick species and canine illness. In addition, more unusual importation routes have been uncovered, such as the importation of Hyalomma lusitanicum on a dog. Some companion animal owners may not be fully aware of the risks associated with ticks, and may not seek advice from a veterinarian before travel or importing a pet. Promoting awareness of ticks and tickborne disease risk during and after travel or animal importation is needed and veterinarians play an importation role in disseminating this information to their clients.